Kolistimetatnatrium Noridem

Colistimethate Sodium, the active ingredient in Kolistimetatnatrium Noridem, is a polymyxin antibiotic presented as a sterile solution for intracerebroventricular and intrathecal use. It treats severe infections caused by susceptible Gram‑negative bacteria, including multidrug‑resistant strains, and is used for central nervous system infections that require direct delivery to the cerebrospinal fluid.

GNH USA supplies Kolistimetatnatrium Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Colistimethate Sodium is employed for serious Gram‑negative bacterial infections and for infections of the central nervous system that require direct administration. - Severe Gram‑negative infections: provides bacterial eradication in patients with multidrug‑resistant organisms. - Central nervous system infections: delivers effective concentrations of antibiotic directly into the CSF for meningitis or ventriculitis. - Multidrug‑resistant Gram‑negative infections: offers a therapeutic option when other antibiotics are ineffective.

Colistimethate Sodium may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nephrotoxicity: elevated serum creatinine and reduced renal function. - Neurotoxicity: paresthesia, dizziness, or visual disturbances. - Ototoxicity: hearing loss or tinnitus. - Nausea or vomiting. - Injection site irritation. - Rash or mild skin reactions.

Serious or Rare Side Effects: - Acute respiratory distress syndrome. - Anaphylactic shock. - Seizures or convulsions. - Severe neuromuscular blockade leading to respiratory failure. - Hemolysis. - Severe electrolyte disturbances.

When using Colistimethate Sodium, clinicians should observe several safety measures. - Renal monitoring: assess kidney function before and during therapy. - Neurotoxicity monitoring: watch for signs of peripheral neuropathy or central effects. - Dose adjustment: modify dosing in patients with impaired renal function. - Concomitant nephrotoxic drugs: avoid or use with caution. - Pregnancy and lactation: safety not established; weigh risks and benefits. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Colistimethate Sodium can interact with other medications, affecting safety and efficacy.

Major Interactions (Avoid): - Aminoglycosides: increased risk of nephrotoxicity. - Vancomycin: additive renal toxicity. - Neuromuscular blocking agents: heightened risk of respiratory paralysis.

Moderate Interactions (Monitor Closely): - Loop diuretics: may exacerbate renal impairment. - Other nephrotoxic antibiotics (e.g., beta‑lactams): monitor renal function. - NSAIDs: potential additive renal effects.